Status:

WITHDRAWN

Pre-lemniscal Radiation Deep Brain Stimulation for ET

Lead Sponsor:

Medical College of Wisconsin

Conditions:

Essential Tremor

Eligibility:

All Genders

21-75 years

Phase:

NA

Brief Summary

The hypothesis is that prelemniscal radiation (RaPRL) deep brain stimulation (DBS) is more effective for axial (head/neck/voice) tremor, and perhaps, appendicular tremor control in essential tremor pa...

Eligibility Criteria

Inclusion

  • diagnosis of essential tremor based on clinical criteria established by the Essential Tremor Consortium
  • Moderate or severe axial-dominant (head/neck/voice) tremor (Tremor Rating Scale \[TRS\] face, tongue, voice, head or trunk tremor score of 2 or above)
  • May have bilateral appendicular tremor
  • Tremor refractory to at least two medications, including primidone and propranolol
  • Age between 21 and 75
  • Male or Female
  • Significant disability due to essential tremor despite medical treatment (TRS score of 2 or above in any one of the items 16-23 \[speaking, feeding other than liquids, bringing liquids to mouth, hygiene, dressing, writing, working, and social activities\])

Exclusion

  • Tremor due to other etiologies
  • Pregnancy
  • Presence of any other neurodegenerative disease
  • Presence of significant cognitive impairment
  • Presence of any medical condition that precludes neurological surgery
  • Patients with another implanted stimulator or metallic implant, e.g. cochlear implant, cardiac pacemaker, spinal cord stimulator, aneurysm clips
  • Patients who have a known need for future MRIs using a full body radio-frequency (RF) coil or a head transmit coil that extends over the chest area or that do not comply with Medtronic's "MRI Guidelines for Medtronic Deep Brain Simulation Systems"
  • Patients with a history of seizures
  • Patients with psychiatric illness that are not well controlled
  • Patients with risk factors for intraoperative or postoperative bleeding (platelet count less than 125,000 per cubic millimeter, PT and PTT not within normal limits)
  • Patients with brain tumors

Key Trial Info

Start Date :

October 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 19 2011

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00634478

Start Date

October 1 2008

End Date

January 19 2011

Last Update

January 21 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Medical College of Wisconsin

Milwaukee, Wisconsin, United States, 53226